Natural history of tobacco withdrawal: implications for smoking cessation treatment

2013 ◽  
pp. 38-52
Author(s):  
Hayden McRobbie ◽  
Oliver West
Author(s):  
David M. Lydon-Staley ◽  
Adam M. Leventhal ◽  
Megan E. Piper ◽  
Robert A. Schnoll ◽  
Danielle S. Bassett

2008 ◽  
Vol 10 (7) ◽  
pp. 1253-1259 ◽  
Author(s):  
Anne Emilie Smith ◽  
Dana Cavallo ◽  
Amanda McFetridge ◽  
Thomas Liss ◽  
Suchitra Krishnan-Sarin

2020 ◽  
Vol 6 (2) ◽  
pp. 116-123
Author(s):  
Witold Zatoński ◽  
Kinga Janik-Koncewicz ◽  
Zuzanna Stępnicka ◽  
Katarzyna Zatońska ◽  
Katarzyna Połtyn-Zaradna ◽  
...  

2019 ◽  
Author(s):  
David M. Lydon-Staley ◽  
Adam M. Leventhal ◽  
Megan E. Piper ◽  
Robert A. Schnoll ◽  
Danielle S Bassett

A recently developed network perspective on tobacco withdrawal posits that withdrawal symptoms causally influence one another across time, rather than simply being indicators of a latent syndrome. Evidence supporting a network perspective would shift the focus of tobacco withdrawal research and intervention toward studying and treating individual withdrawal symptoms and inter-symptom associations. Yet, key questions remain to be addressed, including whether withdrawal symptoms and their interactions are moderated by abstinence and by cessation treatment. Here we examine the evidence for a network perspective on tobacco withdrawal. First, we use data from 668 participants (40% female, 78.29% African American) reporting on their experiences of withdrawal after 16 hours of smoking abstinence and during a non-abstinent state to examine the extent to which individual withdrawal symptoms are differentially impacted by smoking deprivation. Second, we estimate the symptom network structure of tobacco withdrawal during states of smoking satiety and abstinence. Third, we use experience-sampling data from 1210 participants (58.35% female, 86.24% white) undergoing smoking cessation treatment to estimate dynamic symptom networks that describe the interplay among withdrawal symptoms across time. Results indicate (i) differential impact of smoking deprivation on individual withdrawal symptoms, suggesting that symptoms are not interchangeable, (ii) substantial interplay among withdrawal symptoms that shows no evidence of change across periods of smoking satiety and abstinence, and (iii) reductions in the interplay among withdrawal symptoms during smoking cessation treatment. Overall, findings suggest the utility of a network perspective and encourage a greater consideration of the individual symptoms of tobacco withdrawal.


2018 ◽  
Vol 69 (7) ◽  
pp. 1766-1769
Author(s):  
Edith Simona Ianosi ◽  
Paraschiva Postolache ◽  
Luana Andreea Macovei ◽  
Mioara Szathmary ◽  
Simona Szasz ◽  
...  

The fight against smoking through various smoking cessation methods could be very effective by early education especially in young people for preventing the occurrence or the severity of obstructive lung diseases. The aim of the study was to present the impact of varenicline, a selective partial nicotine agonist, in adults of 40-49 year-old, active smokers, recently diagnosed with COPD, from 2009 to 2011, in a Smoking Cessation Center of the Pulmonary Rehabilitation Clinic Iasi, Romania. There were included all male employees, without occupational exposure, active smokers, with a personal history of smoking �10 packs-year cigarettes, recently diagnosed with COPD, who inform consented to be enrolled for counseling and smoking cessation treatment provided by varenicline. All patients received COPD therapy, according to the current GOLD recommendations. The method of evalution the impact of smoking cessation methods consisted in the COPD Assessment Test (CAT) completed by cases before and after 12 weeks program of smoking cessation counseling and therapy and respiratory rehabilitation. The CAT is a short questionnaire, simple and validated tool of COPD symptoms assessment, measuring the severity of COPD on a patient�s quality of life. Results reveals an important decreasing of CAT score with important amelioration of symptoms especially in severe COPD patients. Counseling, smoking cessation and respiratory rehabilitation interventions have shown positive effects of smoking cessation with varenicline among young COPD patients 40-49 year-old.


Sign in / Sign up

Export Citation Format

Share Document